HIGH-DOSE THIOTEPA AND MITOXANTRONE (MITT) FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE (ASCR) FOR REFRACTORY CANCER

被引：0
|
作者：
FIELDS, K [1 ]
ELFENBEIN, G [1 ]
HIEMENZ, J [1 ]
ZORSKY, P [1 ]
PERKINS, J [1 ]
GONZALEZ, J [1 ]
GREENE, S [1 ]
OELSLAGER, P [1 ]
KRONISH, L [1 ]
HOLCOMB, D [1 ]
MACHAK, M [1 ]
SULLIVAN, P [1 ]
PACH, L [1 ]
机构：
[1] UNIV S FLORIDA,DIV BONE MARROW TRANSPLANT,TAMPA,FL 33612
来源：
EXPERIMENTAL HEMATOLOGY | 1992年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：714 / 714
页数：1
相关论文
共 50 条
  • [1] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for recurrent medulloblastoma
    Dunkel, I
    Gardner, S
    Garvin, J
    Goldman, S
    Shi, WJ
    Finlay, J
    NEURO-ONCOLOGY, 2004, 6 (04) : 453 - 453
  • [2] HIGH-DOSE THIOTEPA AND MITOXANTRONE WITH AUTOLOGOUS STEM-CELL REINFUSION FOR REFRACTORY MALIGNANCIES - A PHASE-I-II STUDY
    FIELDS, KK
    ELFENBEIN, GJ
    HIEMENZ, JW
    ZORSKY, PE
    PACH, LD
    CLINICAL RESEARCH, 1992, 40 (02): : A421 - A421
  • [3] A PHASE-I-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND ESCALATING DOSES OF MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH REFRACTORY MALIGNANCIES
    ELLIS, ED
    WILLIAMS, SF
    MOORMEIER, JA
    KAMINER, LS
    BITRAN, JD
    BONE MARROW TRANSPLANTATION, 1990, 6 (06) : 439 - 442
  • [4] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for patients with previously irradiated recurrent medulloblastoma
    Dunkel, Ira
    Gardner, Sharon
    Garvin, James
    Goldman, Stewart
    Shi, Weiji
    Finlay, Jonathan
    NEURO-ONCOLOGY, 2008, 10 (03) : 480 - 480
  • [5] High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma
    Dunkel, IJ
    Boyett, JM
    Yates, A
    Rosenblum, M
    Garvin, JH
    Bostrom, BC
    Goldman, S
    Sender, LS
    Gardner, SL
    Li, H
    Allen, JC
    Finlay, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 222 - 228
  • [6] Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Beyer, J
    Hartmann, JT
    Schwella, N
    Kingreen, D
    Neureither, S
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Derigs, G
    Gerl, A
    Berdel, WE
    Kanz, L
    Siegert, W
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 81 - 88
  • [7] High-dose chemotherapy with autologous bone marrow stem-cell rescue in lung cancer
    Basade, MM
    Gulati, SC
    LANCET, 1996, 347 (9005): : 847 - 848
  • [8] High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma
    Carli, M
    Colombatti, R
    Oberlin, O
    Stevens, M
    Masiero, L
    Frascella, E
    Koscielniak, E
    Treuner, J
    Pinkerton, CR
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2796 - 2803
  • [9] High-dose cyclophosphamide without stem-cell rescue for refractory CIDP
    Brannagan, TH
    Pradhan, A
    Heiman-Patterson, T
    Winkelman, AC
    Styler, MJ
    Topolsky, DL
    Crilley, PA
    Schwartzman, RJ
    Brodsky, I
    Gladstone, DE
    NEUROLOGY, 2002, 58 (12) : 1856 - 1858
  • [10] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE (HDC/ASR) FOR REFRACTORY GERM-CELL CANCER (GCC) IN CHILDREN
    GILLER, R
    LAUER, S
    DAHL, G
    COWAN, M
    FEUSNER, J
    BUNIN, N
    CLOSE, P
    TRIGG, M
    GREFFE, B
    COLORADO, U
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 855 - 855
12345